Puma Biotechnology, Inc.
PBYI
$6.07
$0.172.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | 59.11% | 455.63% | 147.59% | 40.23% |
| Total Depreciation and Amortization | 0.14% | -15.99% | -14.62% | -13.13% | -12.11% |
| Total Amortization of Deferred Charges | -42.86% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,410.14% | -108.20% | -102.03% | -96.47% | -94.46% |
| Change in Net Operating Assets | -185.09% | 57.35% | -658.50% | -588.46% | 80.20% |
| Cash from Operations | 7.41% | 27.32% | 32.98% | -12.15% | 44.09% |
| Capital Expenditure | -26.79% | -44.71% | -27.17% | 16.43% | 60.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -77.20% | 56.46% | 23.67% | 101.41% | -7.36% |
| Cash from Investing | -77.06% | 56.14% | 23.37% | 100.83% | -6.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.33% | -100.00% | -300.00% | -- | -- |
| Issuance of Common Stock | -13.33% | -13.33% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -33.33% | -99.33% | -300.00% | -- | -- |
| Cash from Financing | -33.54% | -100.74% | -297.53% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.61% | 8.64% | -288.00% | -192.35% | -294.90% |